Immune Repertoire Sequencing Market Analysis | CMI

1

• Coherent Market Insights
• Market Research and Business Consulting Services
• https//www.coherentmarketinsights.com/
• COVID-19 Impact Tracker

2
IMMUNE REPERTOIRE SEQUENCING MARKET ANALYSIS

• Immune Repertoire Sequencing Market, By Product
  Type (Assay Kits (T-Cell Receptor Kits, and
  B-Cell Receptor Kits) and Instruments), By
  Application (Cancer Immunotherapy, Biomarker
  Discovery, Autoimmune Diseases, Vaccine
  Development and Efficacy, Transplant Rejection
  and Tolerance, Infectious Diseases, and Other
  Applications), By End User (Diagnostic Labs,
  Biotechnology and Pharmaceutical Companies,
  Academic and Research Institutes, and Others),
  and By Region (North America, Latin America,
  Europe, Asia Pacific, Middle East, and Africa) -
  Size, Share, Outlook, and Opportunity Analysis,
  2018-2026
• The global immune repertoire sequencing market
  size was valued at US 114.3 million in 2017, and
  is expected to witness a CAGR of 5.6 over the
  forecast period (2018 2026).

3
Global Immune Repertoire Sequencing Market Share
() Analysis, By Product Type, 2017
4
Market Drivers

• Increasing Research Development and Demand for
  Genomic and Repertoire Sequencing-based Research
  is expected to Drive Growth of the Immune
  Repertoire Sequencing Market
• Increasing research and development and launches
  of novel products by key players are expected to
  be the major driving force for global immune
  repertoire sequencing market growth in the near
  future. For instance, in 2016, ArcherDX, Inc.
  expanded its product portfolio with the launch of
  Archer Immunoverse immune repertoire sequencing
  assays at the American Society of Hematology
  (ASH). In 2017, ArcherDX, Inc. launched Archer
  Immunoverse B Cell Receptor (BCR) assays to
  characterize the human B cell repertoire.
• According to a study published by Cold Spring
  Harbor Laboratory, in 2017, researchers from
  Stanford University applied immune repertoire
  sequencing to identify disease-related signatures
  in the immune systems of patients with systemic
  sclerosis-related pulmonary hypertension
  (SSc-PAH), a rare chronic autoimmune disease that
  affects the connective tissue. Therefore,
  increasing research on immune repertoire
  sequencing is expected to create a favorable
  environment for immune repertoire sequencing
  market growth in the near future.

5
Market Restraints

• Challenges in immune repertoire sequencing
  include distinguishing biological variations from
  the errors and the bias introduced in different
  steps. Conventional and novel bioinformatics
  techniques such as high throughput screening,
  Haystack Heuristic, and others are not up to the
  mark due to unsatisfactory scalability and
  sensitivity, and limitation in providing
  sufficient and accurate data. Moreover, the
  differences of data generation and processing in
  different laboratories along with the challenges
  in immune repertoire sequencing system are some
  key factors, which may hamper growth of the
  immune repertoire sequencing market size.

6
Immune Repertoire Sequencing Market - Regional
Insights

• On the basis of region, the global immune
  repertoire sequencing market is segmented into
  North America, Latin America, Europe, Asia
  Pacific, Middle East, and Africa. North America
  is expected to hold a dominant position in the
  global immune repertoire sequencing market during
  the forecast period, owing to high presence of
  key industry players in the region (including
  Illumina Inc., Thermo Fisher Scientific, Pacific
  Biosciences, and CD Genomics). These players are
  increasingly focusing on development of novel
  technologies for immune repertoire sequencing.
  For instance, in 2017, 10x Genomics Inc., U.S.
  based company, added B-Cell and 5Unbiased
  Enrichment Kit to its chromium immune repertoire
  profiling solution or immune repertoire
  sequencing.
• Europe is expected to foresee a rapid growth in
  the immune repertoire sequencing market. The
  market in Europe is expected to gain momentum
  during the forecast period, owing to rise in
  funding by the government bodies to support
  international innovative projects and marketable
  innovative products, processes, and services, in
  order to cater unmet medical need. In July 2018,
  Eurostars (a joint program between EUREKA and the
  European Commission) granted US 495,000 to OSE
  Immunotherapeutic SAs project entitled
  Treatment Response Monitoring for Cancer
  Immunotherapies Using Immune Repertoire
  Analysis.

7
Global Immune Repertoire Sequencing Market Value
(US Mn) Y-o-Y Growth (), 2016-2026
8
Immune Repertoire Sequencing Market - Competitive
Landscape

• Key players operating in the global immune
  repertoire sequencing market include Thermo
  Fisher Scientific, Inc., Illumina Inc., ArcherDX,
  Inc., Roche Holding AG, Pacific Biosciences, CD
  Genomics, Atreca, Inc., Adaptive Biotechnologies,
  Oxford Nanopore Technologies, Ltd., Qiagen N.V.,
  Agilent Technologies, Inc., and Takara Bio, Inc.

9

• Request Sample Report
• Request Customization
• Download PDF Brochure
• Talk to Analyst
• Reference https//www.coherentmarketinsights.com
  /market-insight/immune-repertoire-sequencing-marke
  t-1517

10
About Us

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions.
• What we provide
• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

11
Contact Us

• Mr. Shah
• Coherent Market Insights Pvt.Ltd.
• Address 1001 4th Ave, 3200 Seattle, WA 98154,
  U.S.
• Phone [phone]
• Email sales_at_coherentmarketinsights.com

12

• Thank You!
• Kindly follow CMI Social Media Profiles
  for the latest company updates
• Facebook
• Linkedin
• Twitter
• https//www.coherentmarketinsights.com/